Carlos Barcia started his scientific career at the University of Murcia, Spain, at Dr. María-Trinidad Herrero’s Laboratory. As a Ph.D. student, he focused his main research on the inflammatory responses in experimental models of Parkinson’s disease. He also developed a close collaborative work with Dr. Etienne Hirsch at the HÔpital de la Salpêtrière in Paris, where he spent some time of his early Ph.D. fellowship. After his Ph.D. dissertation, he was hired as a Postdoctoral Researcher at the Gene Therapeutics Research Institute (GTRI) from the Cedars Sinai Medical Center and the Department of Medicine at the University of California in Los Angeles (UCLA), Calif, USA. At the GTRI, he mostly studied the inflammatory responses in the CNS after viral infections, and he focused on the analysis of the particular immune responses involving lymphocytes in the brain and the microanatomical structures of CTL immunological synapses in vivo. After his first postdoctoral fellowship, he went back to Spain to work as a Postdoctoral Researcher in the newly created National Network for the Research on Neurodegenerative Diseases (CIBERNED) from the Spanish Ministry at the University of Murcia. Then he was awarded by the RamÓ n y Cajal fellowship, a Spanish version of tenure-track professorship, and he started developing his own new lines of research focusing on the immune responses in different models of brain diseases.
Biography Updated on 8 June 2012